newsAnalysis of the designs of Phase II and III efficacy…
24 January 2020 | By Hannah Balfour (European Pharmaceutical Review)
Analysis of the designs of Phase II and III efficacy trials for HPV vaccines suggest they overstated their effectiveness against cervical cancer, according to researchers.